HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)
Recruiting · NCT07441889 · Registry updated 2026-06-12Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast cancer, breast disorder, breast neoplasm, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder, skin disorder | Recruiting | Phase 1 / Phase 2 | 2026-06-12 | NCT07441889 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| University of Virginia | 201 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| University of Virginia | Charlottesville | United States | 136 |